Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of glycation stress as a geroscience intervention: protocol for a pilot RCT in postmenopausal women.

npj aging·2026
Same author

Methylglyoxal-induced glycation stress promotes aortic stiffening: putative mechanistic roles of oxidative stress and cellular senescence.

Aging·2025
Same author

Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan.

Cell reports·2025
Same author

Growth hormone excess drives liver aging via increased glycation stress.

Aging·2025
Same author

Early menarche and childbirth accelerate aging-related outcomes and age-related diseases: Evidence for antagonistic pleiotropy in humans.

eLife·2025
Same author

Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Aortic Stiffening: Role of Glycation Stress.

Hypertension (Dallas, Tex. : 1979)·2025
Same journal

Metabolic Kinases as Regulators of Inter-Organelle Communication in Aging and Age-Related Diseases.

Aging cell·2026
Same journal

A Non-Canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver.

Aging cell·2026
Same journal

EGR1 Mediates Ursodeoxycholic Acid-Promoted Mitophagy to Prevent Postovulatory Aging of Porcine Oocytes.

Aging cell·2026
Same journal

Interplay of the ENS and Microbiota With Murine Gut Epithelium-Derived Organoids in Aging.

Aging cell·2026
Same journal

Age-Associated Senescence of Decidual Macrophages: A Key Mediator of Adverse Pregnancy Outcomes in Advanced Maternal Age.

Aging cell·2026
Same journal

Correction to "Telomerase Knockout in Myeloid Cells Predisposes Mice to Foam Cell Formation, Dyslipidemia, Lung Fibrosis, and Cardiac Dysfunction".

Aging cell·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Solid Plate-based Dietary Restriction in Caenorhabditis elegans
06:13

Solid Plate-based Dietary Restriction in Caenorhabditis elegans

Published on: May 28, 2011

Dietary restriction and aging, 2009.

Subhash D Katewa1, Pankaj Kapahi

  • 1Buck Institute for Age Research, Novato, CA 94945, USA.

Aging Cell
|January 26, 2010
PubMed
Summary
This summary is machine-generated.

Dietary restriction (DR) extends healthy lifespan across species by influencing conserved pathways like TOR. Research in 2009 revealed key mechanisms, offering hope for delaying aging and age-related diseases.

More Related Videos

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in C. elegans
09:23

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in C. elegans

Published on: August 16, 2017

Related Experiment Videos

Last Updated: Jun 16, 2026

Solid Plate-based Dietary Restriction in Caenorhabditis elegans
06:13

Solid Plate-based Dietary Restriction in Caenorhabditis elegans

Published on: May 28, 2011

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in C. elegans
09:23

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in C. elegans

Published on: August 16, 2017

Area of Science:

  • Gerontology
  • Molecular Biology
  • Nutritional Science

Background:

  • Dietary restriction (DR) is a proven intervention for extending lifespan and healthspan in diverse species.
  • Despite varied protocols, conserved mechanisms underlying DR's effects are increasingly recognized across species.
  • Recent research highlights the TOR pathway's role as a key mediator of DR benefits.

Purpose of the Study:

  • To summarize key 2009 research findings on dietary restriction.
  • To highlight novel mechanistic insights into DR's protective effects against aging.
  • To underscore the conserved nature of DR's impact on lifespan and healthspan.

Main Methods:

  • Review of studies published in 2009 concerning dietary restriction.
  • Analysis of research across multiple model organisms including yeast, worms, flies, mice, monkeys, and humans.
  • Investigation of the TOR pathway's involvement in DR-mediated lifespan extension.

Main Results:

  • Lifespan extension in rapamycin-treated mice suggests TOR pathway involvement in mammalian DR.
  • Conserved relationships in DR effects are emerging across diverse species.
  • 2009 research provided significant mechanistic insights into DR's impact on aging.

Conclusions:

  • The TOR pathway is a critical mediator of dietary restriction effects in mammals.
  • Dietary restriction holds promise for postponing aging and age-related diseases.
  • Continued research across species is crucial for understanding and harnessing DR's benefits.